Gardiner IF - Search Results

Year	Number of Results
2008	1
2009	2
2010	1
2011	3
2012	1
2024	0

1

Group patient visits for Parkinson disease: a randomized feasibility trial.

Dorsey ER, Deuel LM, Beck CA, Gardiner IF, Scoglio NJ, Scott JC, Marshall FJ, Biglan KM. Dorsey ER, et al. Among authors: gardiner if. Neurology. 2011 May 3;76(18):1542-7. doi: 10.1212/WNL.0b013e3182194bad. Epub 2011 Apr 27. Neurology. 2011. PMID: 21525426 Free PMC article. Clinical Trial.

2

A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups.

Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, Coles MA, Burns RS, Marshall FJ, Biglan KM. Dorsey ER, et al. Among authors: gardiner if. Mov Disord. 2010 Oct 15;25(13):2128-35. doi: 10.1002/mds.23160. Mov Disord. 2010. PMID: 20824736

3

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium. Pankratz N, et al. Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687. Ann Neurol. 2012. PMID: 22451204 Free PMC article.

4

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H; Parkinson Study Group DATATOP Investigators. Huang X, et al. PLoS One. 2011;6(8):e22854. doi: 10.1371/journal.pone.0022854. Epub 2011 Aug 11. PLoS One. 2011. PMID: 21853051 Free PMC article.

5

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I; Parkinson Study Group DATATOP and PRECEPT investigators. Marras C, et al. Mov Disord. 2009 Dec 15;24(16):2370-8. doi: 10.1002/mds.22828. Mov Disord. 2009. PMID: 19908310 Clinical Trial.

6

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE; Parkinson Study Group DATATOP and PRECEPT investigators. Marras C, et al. Mov Disord. 2011 Mar;26(4):608-13. doi: 10.1002/mds.23581. Epub 2011 Feb 1. Mov Disord. 2011. PMID: 21287602

7

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group. Hauser RA, et al. Mov Disord. 2009 Mar 15;24(4):564-73. doi: 10.1002/mds.22402. Mov Disord. 2009. PMID: 19086083 Clinical Trial.

8

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE; Parkinson Study Group DATATOP Investigators. Marras C, et al. Mov Disord. 2008 Apr 15;23(5):653-9; quiz 776. doi: 10.1002/mds.21853. Mov Disord. 2008. PMID: 18076084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year